CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol Nitrosative stress drives heart failure with preserved ejection fraction When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease
|<<... 4 5 6 7 8 9 10 ...>>|

Original ResearchVolume 73, Issue 18, 14 May 2019, Pages 2267-2282

JOURNAL：J Am Coll Cardiol. Article Link

Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure

CK Nagaraju, EL Robinson, KR Sipido et al. Keywords: contractile function extracellular matrix fibroblasts inflammation

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top